Hangzhou, China · Founded 2021 · Privately Held (backing)
Developer of innovative drug designed for nervous system disease. Biyo Pharma is based in Hangzhou, China and was founded in 2021. It has raised $14.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$14.3M
Last round
—
Team — not yet on record
No current team members for Biyo Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biyo Pharma with a free account
·Watch Biyo Pharma: the Monday email on marks, rounds and moves
